Asston Pharma Approves Preferential Issue of ₹27.7 Cr Equity

Asston Pharmaceuticals Ltd announced that its Board of Directors, in a meeting held on July 02, 2026, approved a preferential issue of up to 24,10,431 equity shares at ₹115 per share, aggregating to ₹27,71,99,565. These shares are to be issued to non-promoter category investors on a cash basis, subject to shareholder and regulatory approvals. The company also approved convening an Extraordinary General Meeting (EGM) on July 31, 2026, to seek member approval for the preferential allotment. The board meeting commenced at 3:00 PM and concluded at 5:00 PM.